Distribution pattern of 68Ga-DOTATATE in disease-free patients

Nuclear Medicine Communications

Volumn 31, Issue 12, 2010, Pages 1025-1032

  Shastry, Manu ^a   Kayani, Irfan ^a   Wild, Damian ^a   Caplin, Martyn ^b   Visvikis, Dimitris ^c   Gacinovic, Svetislav ^a   Reubi, Jean Claude ^d   Bomanji, Jamshed B ^a  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^b ROYAL FREE HOSPITAL   (United Kingdom)

^c Universite de Bretagne Occidentale   (France)

^d UNIVERSITY OF BERN   (Switzerland)

Author keywords

68Ga DOTA DPhe1; endocrine system; normal; PET computed tomography; positron emission tomography; Tyr3 octreotate

Indexed keywords

1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID PHENYLTYROSINE GA 68; RADIOPHARMACEUTICAL AGENT; SOMATOSTATIN DERIVATIVE; UNCLASSIFIED DRUG; 68GA DOTATATE; 68GA-DOTATATE; DIAGNOSTIC AGENT; ORGANOMETALLIC COMPOUND; SOMATOSTATIN RECEPTOR; SOMATOSTATIN RECEPTOR 2;

ADOLESCENT; ADRENAL GLAND; ADULT; AGED; ARTICLE; BLADDER; CALCULATION; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE FREE INTERVAL; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG UPTAKE; FEMALE; HUMAN; HYPOPHYSIS; IMAGE ANALYSIS; IMAGE RECONSTRUCTION; ISOTOPE LABELING; KIDNEY; LIVER; LYMPH NODE; MALE; NORMAL HUMAN; PANCREAS; PELVIS; POSITRON EMISSION TOMOGRAPHY; PROSTATE; RADIOACTIVITY; SALIVARY GLAND; SPLEEN; STANDARDIZED UPTAKE VALUE; STOMACH WALL; THYROID GLAND; HEALTH; METABOLISM; MIDDLE AGED; REFERENCE VALUE; TRANSPORT AT THE CELLULAR LEVEL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL TRANSPORT; FEMALE; HEALTH; HUMANS; MALE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; POSITRON-EMISSION TOMOGRAPHY; RECEPTORS, SOMATOSTATIN; REFERENCE VALUES; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 78649332447     PISSN: 01433636     EISSN: None     Source Type: Journal    
DOI: 10.1097/MNM.0b013e32833f635e     Document Type: Article

References (36)

1. Reubi JC, Laissue J, Krenning E, Lamberts SW. Somatostatin receptors in human cancer: incidence, characteristics, functional correlates and clinical implications. J Steroid Biochem Mol Biol 1992; 43:27-35.
2. Van den Anker-Lugtenburg PJ, Krenning EP, Oei HY, Van Hagen MP, Gerrits CJ, Reubi JC, et al. Somatostatin receptor scintigraphy in the initial staging of Hodgkin's disease. Br J Haematol 1996; 93:96-103.
3. Reisinger I, Bohuslavitzki KH, Brenner W, Braune S, Dittrich I, Geide A, et al. Somatostatin receptor scintigraphy in small-cell lung cancer: results of a multicenter study. J Nucl Med 1998; 39:224-227.
4. Albérini JL, Meunier B, Denzler B, Devillers A, Tass P, Dazord L, et al. Somatostatin receptor in breast cancer and axillary nodes: study with scintigraphy, histopathology and receptor autoradiography. Breast Cancer Res Treat 2000; 61:21-32.
5. Reubi J, Waser B, Schaer J, Markwalder R. Somatostatin receptors in human prostate and prostate cancer. J Clin Endocrinol Metab 1995; 80:2806-2814.
6. Reubi JC, Waser B. Concomitant expression of several peptide receptors in neuroendocrine tumours: molecular basis for in vivo multireceptor tumour targeting. Eur J Nucl Med Mol Imaging 2003; 30:781-793.
7. Al-Nahhas A, Win Z, Szyszko T, Singh A, Nanni C, Fanti S, et al. Gallium-68 PET: a new frontier in receptor cancer imaging. Anticancer Res 2007; 27:4087-4094.
8. 68Ga-DOTA-Tyr3-octreotide PET in neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and CT. J Nucl Med 2007; 48:508-518.
9. Reubi JC, Schär JC, Waser B, Wenger S, Heppeler A, Schmitt JS, Mäcke HR. Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use. Eur J Nucl Med 2000; 27:273-282.
10. Antunes P, Ginj M, Zhang H, Waser B, Baum RP, Reubi JC, Maecke H. Are radiogallium-labelled DOTA-conjugated somatostatin analogues superior to those labelled with other radiometals? Eur J Nucl Med Mol Imaging 2007; 34:982-993.
11. Henze M, Schuhmacher J, Hipp P, Kowalski J, Becker DW, Doll J, et al. PET imaging of somatostatin receptors using (68Ga)DOTA-D-Phe1-Tyr3-octreotide: first results in patients with meningiomas. J Nucl Med 2001; 42:1053-1056.
12. Maecke HR, Hofmann M, Haberkorn U. (68)Ga-labeled peptides in tumor imaging. J Nucl Med 2005; 46(Suppl 1):172S-178S.
13. 68Ga-DOTATATE (DOTA-DPhe1,Tyr3-octreotate) and 18F-FDG. Cancer 2008; 112:2447-2455.
14. 68Ga. Eur J Nucl Med Mol Imaging 2005; 32:478-485.
15. Zhernosekov KP, Filosofov DV, Baum RP, Aschoff P, Bihl H, Razbash AA, et al. Processing of generator-produced 68Ga for medical application. J Nucl Med 2007; 48:1741-1748.
16. 18F]FDG uptake in PET. Eur J Nucl Med Mol Imaging 2003; 30:344-353.
17. Reubi JC, Waser B, Horisberger U, Krenning E, Lamberts SW, Gebbers JO, et al. In vitro autoradiographic and in vivo scintigraphic localization of somatostatin receptors in human lymphatic tissue. Blood 1993; 82:2143-2151.
18. Reubi JC. Peptide receptors as molecular targets for cancer diagnosis and therapy. Endocr Rev 2003; 24:389-427.
19. Reubi JC, Horisberger U, Kappeler A, Laissue JA. Localization of receptors for vasoactive intestinal peptide, somatostatin, and substance P in distinct compartments of human lymphoid organs. Blood 1998; 92:191-197.
20. Reubi JC, Waser B, Schaer JC, Laissue JA. Somatostatin receptor sst1-sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands. Eur J Nucl Med 2001; 28:836-846.
21. Gugger M, Waser B, Kappeler A, Schonbrunn A, Reubi JC. Cellular detection of sst2A receptors in human gastrointestinal tissue. Gut 2004; 53:1431-1436.
22. Reubi JC, Horisberger U, Studer UE, Waser B, Laissue JA. Human kidney as target for somatostatin: high affinity receptors in tubules and vasa recta. J Clin Endocrinol Metab 1993; 77:1323-1328.
23. Patel YC. Somatostatin and its receptor family. Front Neuroendocrinol 1999; 20:157-198.
24. Gugger M, Waser B, Kappeler A, Schonbrunn A, Reubi JC. Immunohistochemical localization of somatostatin receptor sst2A in human gut and lung tissue: possible implications for physiology and carcinogenesis. Ann N Y Acad Sci 2004; 1014:132-136.
25. Reynaert H, Rombouts K, Vandermonde A, Urbain D, Kumar U, Bioulac-Sage P, et al. Expression of somatostatin receptors in normal and cirrhotic human liver and in hepatocellular carcinoma. Gut 2004; 53: 1180-1189.
26. Reubi JC, Zimmermann A, Jonas S, Waser B, Neuhaus P, Läderach U, et al. Regulatory peptide receptors in human hepatocellular carcinomas. Gut 1999; 45:766-774.
27. Druckenthaner M, Schwarzer C, Ensinger C, Gabriel M, Prommegger R, Riccabona G, et al. Evidence for somatostatin receptor 2 in thyroid tissue. Regul Pept 2007; 138:32-39.
28. Reubi JC, Kappeler A, Waser B, Schonbrunn A, Laissue J. Immunohistochemical localization of somatostatin receptor sst2A in human pancreatic islets. J Clin Endocrinology Metab 1998; 83:3746-3749.
29. Reubi JC, Horisberger U, Waser B, Gebbers JO, Laissue J. Preferential location of somatostatin receptors in germinal centers of human gut lymphoid tissue. Gastroenterology 1992; 103:1207-1214.
30. Reubi JC, Laissue JA, Waser B, Steffen DL, Hipkin RW, Schonbrunn A, et al. Immunohistochemical detection of somatostatin sst2a receptors in the lymphatic, smooth muscular, and peripheral nervous systems of the human gastrointestinal tract: facts and artifacts. J Clin Endocrinol Metab 1999; 84:2942-2950.
31. Corleto VD, Severi C, Romano G, Tattoli I, Weber HC, Stridsberg M, et al. Somatostatin receptor subtypes mediate contractility on human colonic smooth muscle cells. Neurogastroenterol Motil 2006; 18:217-225.
32. 68Ga-DOTA-octreotate PET imaging. Eur J Nucl Med Mol Imaging 2007; 34:S192.
33. Kennedy JW, Dluhy RG. The biology and clinical relevance of somatostatin receptor scintigraphy in adrenal tumor management. Yale J Biol Med 1997; 70:565-575.
34. Epelbaum J, Bertherat J, Prevost G, Kordon C, Meyerhof W, Wulfsen I, et al. Molecular and pharmacological characterization of somatostatin receptor subtypes in adrenal, extraadrenal, and malignant pheochromocytomas. J Clin Endocrinol Metab 1995; 80:1837-1844.
35. Lichtenauer-Kaligis EGR, Van Hagen PM, Lamberts SWJ, Hofland LJ. Somatostatin receptor subtypes in human immune cells. Eur J Endocrinol 2000; 143:S21-S25.
36. Oomen SP, Hofland LJ, Van Hagen PM, Lamberts SW, Touw IP. Somatostatin receptors in the haematopoietic system. Eur J Endocrinol 2000; 143 (Suppl 1):S9-S14.